← Browse by Condition
Medical Condition

metabolic syndrome

Total Trials
10
Recruiting Now
10
Trial Phases
Phase 2, Phase 2, Phase 3, EARLY_Phase 1

ClinicalMetric tracks all active clinical trials for metabolic syndrome sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — metabolic syndrome Clinical Trials

How many clinical trials are currently recruiting for metabolic syndrome?
ClinicalMetric currently tracks 10 actively recruiting clinical trials for metabolic syndrome, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 10. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for metabolic syndrome?
metabolic syndrome research spans Phase 1 (1 trial), Phase 2 (2 trials), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a metabolic syndrome clinical trial?
Eligibility criteria for metabolic syndrome trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Phase 2
2
Phase 3
1
Top Sponsors
Regina Grazuleviciene 1 trial
Universiti Putra Malaysia 1 trial
Sun Yat-sen University 1 trial
Shanghai Changzheng Hospital 1 trial
Shanghai Jiao Tong University School of Medicine 1 trial

Recruiting Clinical Trials

NCT07111208
Recruiting
Ambient Air and Noise Effect on Cardiovascular Health Risk and Lifestyle Intervention to Attenuate It (METSGREEN)
Enrollment
180 pts
Location
Lithuania
Sponsor
Regina Grazuleviciene
View Trial →
NCT07181655
Recruiting
The Effectiveness of Intermittent Fasting, Caloric Restriction and Physical Activity On Metabolic Syndrome
Enrollment
140 pts
Location
Malaysia
Sponsor
Universiti Putra Malaysia
View Trial →
NCT03569735
Recruiting
Nanshan Elderly Cohort Study
Enrollment
20,000 pts
Location
China
Sponsor
Sun Yat-sen University
View Trial →
NCT07043166
Recruiting
Cardiovascular-Kidney-Metabolic Syndrome in Shanghai Zicitizens
Enrollment
4,094 pts
Location
China
Sponsor
Shanghai Changzheng Hospital
View Trial →
NCT01084967
Recruiting
Genetics of Obesity in Chinese Youngs
Enrollment
8,000 pts
Location
China
Sponsor
Shanghai Jiao Tong University ...
View Trial →
NCT06515652
Recruiting
To Compare the Effects of Herbal Medicines With Traditional Allopathic Medicines in Cases of Patients With Metabolic Syndrome
Enrollment
200 pts
Location
Pakistan
Sponsor
Hamdard University
View Trial →
NCT06172335
Recruiting
Effects of Cetoleic Acid on Atherosclerosis (Ketolinsyre's Effekt på Aterosklerose)
Enrollment
70 pts
Location
Norway
Sponsor
Oslo University Hospital
View Trial →
NCT07189234 Phase 2
Recruiting
Long Term Impact of Time-Restricted Eating on Parameters of Cardiometabolic Health
Enrollment
140 pts
Location
United States
Sponsor
University of California, San ...
View Trial →
NCT07625332 Phase 2, Phase 3
Recruiting
Pilot Study of Galantamine to Treat Metabolic Syndrome in People With Chronic Traumatic Spinal Cord Injury (SCI)
Enrollment
60 pts
Location
United States
Sponsor
Northwell Health
View Trial →
NCT05802121 EARLY_Phase 1
Recruiting
Akkermansia Muciniphilia and Metabolic Side Effects of ADT
Enrollment
30 pts
Location
Canada
Sponsor
Western University
View Trial →

Related Conditions

obesity (3) cardiovascular diseases cvd (2) hypertension (2) diabetes (2) air pollution exposure (1) environmental exposure (1) health behavior change (1) type 2 diabetes mellitus (1) cardiovascular diseases (1) stroke (1) sarcopenia (1) chronic kidney disease (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology